|
MLLT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.53890000000368E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.151960E-04 |
| Normal-vs-Stage2 |
8.10290000000657E-05 |
| Normal-vs-Stage3 |
7.484200E-02 |
| Normal-vs-Stage4 |
1.883850E-03 |
| Stage1-vs-Stage2 |
2.631600E-01 |
| Stage1-vs-Stage3 |
5.020200E-01 |
| Stage1-vs-Stage4 |
5.754400E-01 |
| Stage2-vs-Stage3 |
1.846820E-01 |
| Stage2-vs-Stage4 |
9.582600E-01 |
| Stage3-vs-Stage4 |
3.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.31410000000643E-05 |
| Normal-vs-AfricanAmerican |
4.995200E-04 |
| Normal-vs-Asian |
3.537600E-03 |
| Caucasian-vs-AfricanAmerican |
8.518000E-01 |
| Caucasian-vs-Asian |
3.841200E-01 |
| AfricanAmerican-vs-Asian |
2.959800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.9686999999965E-06 |
| Normal-vs-Female |
7.255800E-02 |
| Male-vs-Female |
7.326500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.619800E-04 |
| Normal-vs-Extreme_Weight |
1.543680E-03 |
| Normal-vs-Obese |
2.345900E-02 |
| Normal-vs-Extreme_Obese |
2.578200E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.882000E-01 |
| Normal_Weight-vs-Obese |
9.322500E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.490000E-01 |
| Extreme_Weight-vs-Obese |
3.320600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.433400E-01 |
| Obese-vs-Extreme_Obese |
2.882600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.797000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.127630E-02 |
| Normal-vs-Age(61-80Yrs) |
5.05659999983088E-07 |
| Normal-vs-Age(81-100Yrs) |
1.59749999999459E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.902300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.612270E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.036490E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.001940E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.000100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.167580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.863700E-03 |
| Normal-VS-Type2 PRCC |
1.65519997707975E-09 |
| Normal-VS-KIRP CIMP |
7.576800E-01 |
| Normal-VS-Unclassified PRCC |
4.443600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.18089999959714E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.756000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.683400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.597810E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.478700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.168100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79159999946776E-07 |
| Normal-vs-N1 |
1.391430E-01 |
| Normal-vs-N2 |
1.843650E-02 |
| N0-vs-N1 |
3.831800E-02 |
| N0-vs-N2 |
9.252000E-01 |
| N1-vs-N2 |
3.914800E-01 |
|
|
